Elutia Announces First Quarter 2024 Results: SimpliDerm® Sales Increase 55%, CanGaroo®RM on Track for Second Quarter 2024 FDA Clearance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/12/2026

1. ADBE
2. RH
3. NVDA
4. USO
5. SPCX
6. NDAQ
7. MH
8. TFPM
9. BBW
10. RKLB

Go back to Elutia Announces First Quarter 2024 Results: SimpliDerm® Sales Increase 55%, CanGaroo®RM on Track for Second Quarter 2024 FDA Clearance
(NASDAQ: AZYO) Delayed: 1.49 --0 (-0%)
Previous Close $1.49    52 Week High $ 
Open $0.00    52 Week Low $ 
Day High $1.49    P/E N/A 
Day Low $1.49    EPS $ 
Volume 33,510       

(NASDAQ: ELUT) Delayed: 0.96 -25.49 (96.37%)
Previous Close $26.45    52 Week High $ 
Open $0.96    52 Week Low $ 
Day High $0.96    P/E N/A 
Day Low $0.96    EPS $ 
Volume 125